Survival following radiotherapy in young women with localized early ‐stage breast cancer according to molecular subtypes

ConclusionsRT could offer significant survival benefit in luminal ‐A, luminal‐B, and especially HER2‐enriched young early‐stage breast cancer female patients. The results enabled clinicians to predict the benefits of RT and improve evidence‐based treatment for breast cancer patients.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research